Characteristics | Patients (n = 60) | LgR5 EAC | p-value | |
---|---|---|---|---|
 |  | low | high |  |
Age (y) | Â | Â | Â | .069 |
<66 | 30 (50%) | 10 (33%) | 20 (67%) | Â |
≥66 | 30 (50%) | 18 (60%) | 12 (40%) |  |
Gender | Â | Â | Â | 1.00 |
Male | 52 (87%) | 24 (46%) | 28 (34%) | Â |
Female | 8 (13%) | 4 (50%) | 4 (50%) | Â |
Histological classification | Â | Â | Â | .577a |
G1 | 17 (28%) | 11 (65%) | 6 (35%) | Â |
G2 | 22 (37%) | 11 (50%) | 11 (50%) | Â |
G3/4 | 21 (33%) | 6 (29%) | 15 (71%) | Â |
Depth of invasion | Â | Â | Â | .259b |
pT1 | 16 (27%) | 11 (69%) | 5 (31%) | Â |
pT2 | 26 (43%) | 11 (42%) | 15 (58%) | Â |
pT3 | 10 (17%) | 4 (40%) | 6 (60%) | Â |
pT4 | 8 (13%) | 2 (25%) | 6 (75%) | Â |
Lymph nodes metastasis | Â | Â | Â | .007 |
pN0 | 23 (38%) | 16 (70%) | 7 (30%) | Â |
pN1-3 | 37 (62%) | 12 (32%) | 25 (68%) | Â |
UICC stage | Â | Â | Â | .573c |
UICC I | 14 (23%) | 10 (71%) | 4 (29%) | Â |
UICC II | 28 (47%) | 11 (39%) | 17 (61%) | Â |
UICC III | 18 (30%) | 7 (39%) | 11 (61%) | Â |
UICC IV | 0 (0%) | 0 (0%) | 0 (0%) | Â |
Median OS (m) | 43 m | 32 (n = 28) | 24 (n = 32) | Â |